HEDIEH TERMEH: Open Payments
NPI 1073896395 · VAN NUYS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,243 in 22 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,243
Travel & lodging: $1,245Food & beverage: $999
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 11 | $1,550 |
| Phathom Pharmaceuticals, Inc. | 2 | $273 |
| Lilly USA, LLC | 2 | $140 |
| Mirum Pharmaceuticals, Inc. | 1 | $131 |
| Celltrion USA Inc. | 3 | $72 |
| Ipsen Biopharmaceuticals, Inc | 1 | $31 |
| RedHill Biopharma Inc. | 1 | $27 |
| Intercept Pharmaceuticals, Inc. | 1 | $20 |
Products named: VOQUEZNA, Livmarli, VEGZELMA, IQIRVO, Talicia, OCALIVA, OMVOH.
Industry payments across CA — which companies pay providers there.
